The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
0302004 Informal Interpretation
20030354: Prudential Financial, Inc.; Skandia Insurance Company Ltd. (publ)
20030353: Heartland Industrial Partners, L.P.; Linsalata Capital Partners Fund II, L.P.
20030343: Level 3 Communications, Inc.; Carl C. Icahn
20030340: Fidelity National Financial, Inc.; ANFI, Inc.
20030280: Verizon Communications Inc.; Cablevision Systems Corporation
20030189: The Lundbeck Foundation; Synaptic Pharmaceutical Corporation
0302003 Informal Interpretation
Baxter International Inc., and Wyeth, In the Matter of
Baxter settled Commission concerns stemming from its $316 million proposed acquisition of Wyeth Corporation's generic injectable drug business and agreed to divest several pharmaceutical products. The Commission charged that the acquisition would reduce competition in the manufacture and sale of propofol (a general anesthetic); new injectable iron replacement therapies; metocloprarnide (used to treat nausea); and vecuronium and pancuronium (neuromuscular blocking agents used to temporarily freeze muscles during surgery). The consent order requires divestitures in each of the pharmaceutical markets.